Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dna X (SONM) Equity Ratio (2018 - 2025)

Dna X's Equity Ratio history spans 8 years, with the latest figure at 0.18 for Q4 2025.

  • Quarterly results put Equity Ratio at 0.18 for Q4 2025, down 26.34% from a year ago — trailing twelve months through Dec 2025 was 0.18 (down 26.34% YoY), and the annual figure for FY2025 was 0.18, down 26.34%.
  • Equity Ratio for Q4 2025 was 0.18 at Dna X, down from 0.02 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.48 in Q1 2021 to a low of 0.18 in Q4 2025.
  • The 5-year median for Equity Ratio is 0.35 (2021), against an average of 0.26.
  • The sharpest move saw Equity Ratio skyrocketed 114.24% in 2023, then crashed 135.94% in 2024.
  • Year by year, Equity Ratio stood at 0.45 in 2021, then dropped by 17.65% to 0.37 in 2022, then rose by 6.9% to 0.4 in 2023, then plummeted by 135.94% to 0.14 in 2024, then dropped by 26.34% to 0.18 in 2025.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 0.18, 0.02, and 0.04 for Q4 2025, Q3 2025, and Q2 2025 respectively.